Aptorum Group Limited - Common Stock (NQ:APM)

0.7000 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptorum Group Limited - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 24, 2022

Welcome back, trader! It's time to get this week going with a breakdown of the biggest pre-market stock movers for Monday!

Via InvestorPlace

53 Biggest Movers From Friday ↗

January 24, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 21, 2022

Gainers Mustang Bio (NASDAQ:MBIO) shares ...

Via Benzinga

34 Stocks Moving In Friday's Mid-Day Session ↗

January 21, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday. Bon Natural Life Limited (NASDAQ: BON) shares gained 22% to $3.91....

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 21, 2022

Gainers Idera Pharmaceuticals (NASDAQ:IDRA) stock rose 13.0% to $0.71 during Friday's pre-market session. The market value of their outstanding shares is at $37.7...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 21, 2022

Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

18 Stocks Moving in Friday's Pre-Market Session ↗

January 21, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares rose 422% to $9.93 in pre-market trading after gaining around 9% on Thursday. Barfresh Food Group Inc. (...

Via Benzinga

48 Biggest Movers From Yesterday ↗

January 21, 2022

Gainers Aptorum Group Limited (NYSE: APM) shares jumped 38.5% to close at $1.69 on Thursday after the company announced it received FDA Orphan Drug designation for...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 20, 2022

Gainers TCR2 Therapeutics (NASDAQ:TCRR) s...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 20, 2022

Gainers Aptorum Group (NASDAQ:APM) stock increased by 32.8% to $1.62 during Thursday's regular session. Aptorum Group's stock is trading at a volume of 86.4...

Via Benzinga

Stocks Roar Back to Life Despite Alarming Jobs Data ↗

January 20, 2022

Stocks are staging a massive comeback today, with the Dow Jones Industrial Average last seen up 428 points midday. Both the S&P 500 Index and Nasdaq Composite are sporting solid midday gains as well.

Via Talk Markets

Aptorum Shares Rise After FDA Orphan Drug Tag For Repurposed Compound For Pediatric Cancer ↗

January 20, 2022

The FDA has granted Orphan Drug Designation to Aptorum Group Limited (NASDAQ: APM) SACT-1, a repurposed small molecule compound for Neuroblastoma. Aptorum...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 20, 2022

Gainers Baudax Bio (NASDAQ:BXRX) stock rose 32.2% to $0.26 during Thursday's pre-market session. The company's market cap stands at $21.9 million. Aptorum Group (...

Via Benzinga

Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma

January 20, 2022

From Aptorum Group Limited

Via Business Wire

Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma

January 18, 2022

From Aptorum Group Limited

Via Business Wire

Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology

January 10, 2022

From Aptorum Group Limited

Via Business Wire

Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers

January 10, 2022

From Aptorum Group Limited

Via Business Wire

Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma

January 10, 2022

From Aptorum Group Limited

Via Business Wire

Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders

December 03, 2021

From Aptorum Group Limited

Via Business Wire

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 2, 2021

October 19, 2021

From Aptorum Group Limited

Via Business Wire

Aptorum Group Limited Interview to Air on Bloomberg U.S.

October 15, 2021

From Aptorum Group Limited

Via Business Wire

Aptorum To Start Testing SACT-1 In Neuroblastoma Patients ↗

September 15, 2021

The FDA has signed off Aptorum Group Limited's (NASDAQ: APM) IND application to initiate clinical trials of SACT-1 for neuroblastoma. The IND-opening trial is...

Via Benzinga

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021

September 15, 2021

From Aptorum Group Limited

Via Business Wire

Aptorum Group Limited Has Received IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma

September 15, 2021

From Aptorum Group Limited

Via Business Wire

Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate ↗

July 12, 2021

Aptorum Group Limited (NASDAQ: APM) announces further interim data from its ongoing Phase 1 trial for ALS-4 targeting Staphylococcus aureus. Specifically,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 12, 2021

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life...

Via Benzinga

Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus aureus

July 12, 2021

From Aptorum Group Limited

Via Business Wire

Aptorum Group Interview to Air on Bloomberg Television U.S. on the RedChip Money Report

July 09, 2021

From Aptorum Group Limited

Via Business Wire

58 Biggest Movers From Friday ↗

June 21, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....

Via Benzinga

Aptorum Group CEO Subscribed Shares In The Company

May 26, 2021

From Aptorum Group Limited

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.